Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Research reveals administration of ineffective COVID-19 treatments after FDA deauthorization

Monoclonal antibodies are laboratory-designed treatments tailor-made to fight specific infections. In early 2021, the U.S. Food & Drug Administration issued emergency use authorization for two monoclonal antibodies (bamlanivimab/etesevimab and casirivimab/imdevimab) for the treatment of mild to moderate COVID-19 in high-risk, non-hospitalized patients.

30 Aug 2022

Study reveals impacts of multiple SARS-CoV-2 Wuhan-based vaccinations on the Omicron variant of concern

In a new study, researchers analyzed the influence of multiple shots of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Wuhan strain vaccinations on the Omicron variant.

30 Aug 2022

Novel mechanism identified that SARS-CoV-2 uses to suppress antiviral responses to make the cell more permissive to infection

Researchers assessed the impact of SARS-CoV-2 ORF-6 on innate immune signaling.

30 Aug 2022

Researchers report the exceptional binding and neutralizing potency of an ACE2 decoy against SARS-CoV-2 variants

Researchers explored the activity of an ACE2 decoy against SARS-CoV-2 Omicron variant.

30 Aug 2022

Exploration of glycan shield structure of sarbecoviruses provides new insights into developing pan-coronavirus vaccines

A new study explored the glycan shield diversity of sarbecoviruses, furthering the knowledge for developing broad-range pan-coronavirus vaccines.

30 Aug 2022

Study reveals a 'stealing' mechanism that contributes to antibody diversity

A few years ago, Professor Kathrin de la Rosa and her colleagues in the lab of the Swiss immunologist Antonio Lanzavecchia made an unusual discovery.

29 Aug 2022

Using organic metal nanohybrid structures to simultaneously identify multiple food poisoning bacteria

Osaka Metropolitan University scientists have developed a simple, rapid method to simultaneously identify multiple food poisoning bacteria, based on color differences in the scattered light by nanometer-scaled organic metal nanohybrid structures (NHs) that bind via antibodies to those bacteria.

29 Aug 2022

Microscopy technique enables visualization of unseen nanostructures within cells and tissues

Inside a living cell, proteins and other molecules are often tightly packed together. These dense clusters can be difficult to image because the fluorescent labels used to make them visible can't wedge themselves in between the molecules.

29 Aug 2022

How does the maternal immune response balance SARS-CoV-2 antiviral responses with transplacental transfer of protection to the fetus?

Researchers found that in SARS-CoV-2 maternal infection, the balance between antiviral response and transplacental transfer of humoral and cellular protection relies on maternal IL-6 and IL10.

29 Aug 2022

Study shows SARS-CoV-2 infection provides strong protection from reinfection

Researchers assess the durability and effectiveness of immune responses against SARS-CoV-2 in terms of spike-binding antibody titers.

29 Aug 2022

Research characterizes clinical and epidemiologic features of SARS-CoV-2 in pets

Researchers analyze the clinical and epidemiological features of SARS-CoV-2 infection in dogs and cats in the United States.

28 Aug 2022

Researchers explore the relationship between vitamin D levels and T. gondii infection

Announcing a new article publication for Zoonoses journal. Vitamin D deficiency is associated with high susceptibility to infections.

26 Aug 2022

New study provides comparison of replicating and non-replicating vaccines against SARS-CoV-2

A new study reported a single-cell adenovirus (SC-Ad) which replicates the antigen genes substantially without producing infectious progeny.

26 Aug 2022

Susceptibility of deer mice and California mice to COVID-19

In a new study, researchers assessed the susceptibility of deer mice and California mice to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

25 Aug 2022

Study investigates factors that influence immune responses over 15 months after SARS-CoV-2 infection

In a new study, the long-term humoral immunity to SARS-CoV-2 was investigated.

25 Aug 2022

Study suggests inclusion of the Omicron BA.5 strain in a SARS-CoV-2 vaccine would be beneficial in protection against this widely circulating variant

Researchers explored neutralizing antibodies against SARS-CoV-2 Omicron BA.1, BA.2, and BA.5 lineage infected patients.

25 Aug 2022

Survey reveals clear differences among the NYC boroughs in COVID behaviors and attitudes

As the nation follows new CDC recommendations to relax COVID-19 restrictions, a new survey of 2,500 New Yorkers conducted by the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) revealed clear differences among the boroughs in vaccine and booster uptake, childhood vaccination, treatment when sick and general trust in the safety and effectiveness of the vaccine.

24 Aug 2022

Vertical transfer of humoral immune protection after maternal SARS-CoV-2 vaccination

In a new study, researchers assessed the presence, durability, and neutralization potency of immunoglobulin G and IgA antibodies against SARS-CoV-2 in breastfeeding infant stools, maternal plasma, and breast milk following maternal COVID-19 vaccination.

24 Aug 2022

Researchers identify a potential new therapeutic approach to fight angioimmunoblastic T-cell lymphoma

A type of blood cell cancer called angioimmunoblastic T-cell lymphoma (AITL) can develop as mutations accumulate with age in the stem cells from which the T cells in the blood develop.

24 Aug 2022

The role of SARS-CoV-2-specific T cells induced by infection, vaccination, or their combination in disease protection

Researchers evaluated how SARS-CoV-2-specific-T lymphocytes induced by infection, vaccination, or both conferred protection against severe COVID-19.

24 Aug 2022

Antibody News and Research

Further Reading

Research reveals administration of ineffective COVID-19 treatments after FDA deauthorization

Study reveals impacts of multiple SARS-CoV-2 Wuhan-based vaccinations on the Omicron variant of concern

Novel mechanism identified that SARS-CoV-2 uses to suppress antiviral responses to make the cell more permissive to infection

Researchers report the exceptional binding and neutralizing potency of an ACE2 decoy against SARS-CoV-2 variants

Exploration of glycan shield structure of sarbecoviruses provides new insights into developing pan-coronavirus vaccines

Study reveals a 'stealing' mechanism that contributes to antibody diversity

Using organic metal nanohybrid structures to simultaneously identify multiple food poisoning bacteria

Microscopy technique enables visualization of unseen nanostructures within cells and tissues

How does the maternal immune response balance SARS-CoV-2 antiviral responses with transplacental transfer of protection to the fetus?

Study shows SARS-CoV-2 infection provides strong protection from reinfection

Research characterizes clinical and epidemiologic features of SARS-CoV-2 in pets

Researchers explore the relationship between vitamin D levels and T. gondii infection

New study provides comparison of replicating and non-replicating vaccines against SARS-CoV-2

Susceptibility of deer mice and California mice to COVID-19

Study investigates factors that influence immune responses over 15 months after SARS-CoV-2 infection

Study suggests inclusion of the Omicron BA.5 strain in a SARS-CoV-2 vaccine would be beneficial in protection against this widely circulating variant

Survey reveals clear differences among the NYC boroughs in COVID behaviors and attitudes

Vertical transfer of humoral immune protection after maternal SARS-CoV-2 vaccination

Researchers identify a potential new therapeutic approach to fight angioimmunoblastic T-cell lymphoma

The role of SARS-CoV-2-specific T cells induced by infection, vaccination, or their combination in disease protection

eBook: End-to-end solutions for bispecific antibody development eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo